Evidence map›Paper›PMID 42183246›Full record

ReviewFrontiers in immunology2026

A shared stress-inflammation signalling architecture underlying chronic disease and multimorbidity.

Wolfgang Kopp

Abstract readReview
In one paragraph

Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Wolfgang KoppIndependent Researcher, Graz, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic non-communicable diseases are conventionally classified as distinct clinical entities, yet multimorbidity has become the dominant phenotype in modern populations. Converging experimental, clinical and epidemiological evidence indicates that metabolic overload-characterised by persistent hyperinsulinaemia, insulin resistance and nutrient-driven anabolic signalling-acts as a central amplifier of conserved stress-response systems and chronic low-grade inflammatory signalling. Under contemporary exposome conditions, sustained metabolic stress chronically engages sympathetic and renin-angiotensin-aldosterone signalling, oxidative stress pathways and innate immune activation, establishing a tightly coupled feed-forward network that stabilises pathological states across organ systems. Here, I synthesise mechanistic data from endocrinology, immunometabolism, vascular biology and ageing research to propose a unified stress-signalling architecture linking systemic stress axes to shared intracellular integration hubs. These include inflammatory transcriptional regulators (NF-κB, AP-1), stress-activated kinases (MAPKs), and nutrient- and oxygen-sensing pathways centred on PI3K-Akt-mTOR and HIF-1α, with additional modulation by Notch signalling. When cytoprotective buffering and stress-resolution mechanisms-particularly NRF2 activity, autophagy and mitochondrial resilience-are insufficient, persistent activation of these hubs enforces inflammatory tone, metabolic inflexibility, impaired proteostasis and maladaptive tissue remodelling, providing a mechanistic explanation for phenotypic convergence across cardiometabolic, inflammatory, degenerative and hyperplastic diseases. Importantly, epidemiological and anthropological observations indicate that multimorbidity is not an inevitable consequence of ageing per se, but instead reflects environmentally contingent persistence of stress-response programmes rather than intrinsic ageing trajectories. Framing chronic disease through this integrated metabolic-stress signalling architecture positions multimorbidity as a mismatch phenotype rather than a programmed endpoint of human longevity, and highlights upstream stress regulation and restoration of metabolic resilience as central targets for system-level prevention and intervention.

Indexed as

InflammationSignal TransductionStress, PhysiologicalAgingAnimalsChronic DiseaseHumansMultimorbidityOxidative Stresschronic inflammationimmunometabolismmetabolic stressmultimorbiditystress signallingsystems immunology

Identifiers

PMID42183246
PMCPMC13189770

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.